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Abstract
Aims/hypothesis Exercise represents an effective interven-
tional strategy to improve glycaemic control in type 2 diabetes
patients. However, the impact of exercise intensity on the
benefits of exercise training remains to be established. In the
present study, we compared the clinical benefits of 6 months
of continuous low- to moderate-intensity exercise training
with those of continuous moderate- to high-intensity exercise
training, matched for energy expenditure, in obese type 2
diabetes patients.
Methods Fifty male obese type 2 diabetes patients (age 59±
8 years, BMI 32±4 kg/m2) participated in a 6 month
continuous endurance-type exercise training programme.
All participants performed three supervised exercise sessions
per week, either 55 min at 50% of whole body peak oxygen
uptake V

O2peak
 
(low to moderate intensity) or 40 min at
75% of V

O2peak (moderate to high intensity). Oral glucose
tolerance, blood glycated haemoglobin, lipid profile, body
composition, maximal workload capacity, whole body and
skeletal muscle oxidative capacity and skeletal muscle fibre
type composition were assessed before and after 2 and
6 months of intervention.
Results The entire 6 month intervention programme was
completed by 37 participants. Continuous endurance-type
exercise training reduced blood glycated haemoglobin levels,
LDL-cholesterol concentrations, bodyweight and leg fat mass,
and increased V

O2peak, lean muscle mass and skeletal muscle
cytochrome c oxidase and citrate synthase activity (p<0.05).
No differences were observed between the groups training at
low to moderate or moderate to high intensity.
Conclusions/interpretation When matched for energy cost,
prolonged continuous low- to moderate-intensity endurance-
type exercise training is equally effective as continuous
moderate- to high-intensity training in lowering blood
glycated haemoglobin and increasing whole body and skeletal
muscle oxidative capacity in obese type 2 diabetes patients.
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HI Moderate to high intensity
LI Low to moderate intensity
V

O2peak Whole body peak oxygen uptake
Introduction
Lifestyle intervention programmes that combine regular
exercise, dietary modulation and/or oral blood-glucose-
lowering medication have proven an effective therapeutic
strategy in type 2 diabetes [1–3]. Continuous endurance-type
exercise training has been shown to lower blood HbA1c,
increase insulin sensitivity, improve the risk profile for
cardiovascular disease and reduce adipose-tissue mass in
patients with type 2 diabetes [4, 5]. In addition, exercise
training represents the only interventional strategy that has
consistently been shown to improve whole body and skeletal
muscle oxidative capacity [6]. In accordance, recently
published standards of medical care for type 2 diabetes
underline the importance of exercise prescription [7].
However, the clinical guidelines do not include detailed
information on the preferred exercise modalities that should
be implemented to maximise the clinical benefits of
exercise intervention in diabetes patients [7]. Exercise
intensity has been suggested to represent one of the more
important exercise modalities that determine the clinical
outcome of exercise interventions [1, 4]. This has been
attributed to the inverse relationship between exercise
intensity and glycogen use within the muscle [8, 9]. The
magnitude of the increase in insulin sensitivity following an
acute bout of continuous endurance-type exercise has been
associated with the extent of muscle glycogen depletion and
the subsequent repletion rate [10, 11]. Whether such
differences in the acute glucoregulatory effect of a single
bout of exercise also translate into improvements in
glycaemic control following more prolonged endurance-
type exercise interventions in type 2 diabetes patients
remains speculative [12, 13].
Long-term exercise intervention studies investigating the
impact of continuous low- to moderate-intensity (LI) vs high-
intensity endurance-type exercise training on glycaemic
control in healthy and/or glucose-intolerant individuals have
reported high intensity exercise training to be, when compared
with low-intensity endurance-type exercise training, less [14],
equally [15, 16] or more [17] effective. However, long-term
exercise intervention studies in type 2 diabetes patients
investigating the clinical benefits of either continuous LI or
moderate- to high-intensity (HI) exercise training remain
lacking.
The preference for implementing either an LI or HI
exercise regimen in a continuous endurance-type exercise
intervention programme for patients with type 2 diabetes is of
great clinical relevance, especially when considering the
inverse relationship between exercise intensity and patient
compliance [18]. As long-term patient compliance and
adherence are required to improve glycaemic control
effectively and reduce the prevalence of diabetes-related
co-morbidities, it is essential to minimise patient dropout [4].
Therefore, the present study compares the clinical
benefits of continuous LI vs HI exercise training, matched
for total energy cost, in obese type 2 diabetes patients.
Changes in blood HbA1c content, indices of oral glucose
tolerance and/or whole body insulin sensitivity, blood lipid
profile, body composition, exercise performance and whole
body and skeletal muscle oxidative capacity, as well as
muscle fibre type composition, were assessed prior to and
after 2 and 6 months of either continuous LI or HI
endurance-type exercise training.
Methods
Participants Fifty male obese type 2 diabetes patients were
selected to participate in this study. Participants had been
diagnosed with type 2 diabetes for at least 12 months and
were all treated with oral blood-glucose-lowering medica-
tion. Participants were sedentary and had not participated in
any regular exercise programme for at least 5 years.
Participants were informed about the nature and risks of
the experimental procedures before their written informed
consent was obtained. This study was approved by the
medical ethical committee of the Virga Jesse Hospital.
Study design All participants participated in a 6 month
exercise intervention programme. Prior to the start of the
programme and after 2 and 6 months of intervention blood
glycated haemoglobin content, basal plasma glucose and
insulin concentrations, plasma lipid profile, oral glucose
tolerance, body composition, whole body oxidative capac-
ity, maximal workload capacity, skeletal muscle oxidative
enzyme activity and muscle fibre type composition were
assessed after an overnight fast. Measurements were
performed prior to intervention and 4 and 8 days after the
last exercise training session at 2 and 6 months of
intervention (see Fig. 1). Three days prior to the oral
glucose tolerance test patients abstained from taking oral
blood-glucose and/or lipid-lowering medication. All meas-
urements were performed as depicted in Fig. 1, and were
executed at the same time of day prior to and after 2 and
6 months of intervention.
Diet and physical activity prior to testing All participants
maintained normal physical activity and dietary patterns,
and refrained from exhaustive physical exercise 3 days
prior to each experimental day. In addition, participants
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recorded dietary intake over 2 days prior to the OGTT and
copied their diet prior to the 2 and 6 month follow-up
assessments. The evening before each test day, all partic-
ipants received the same standard meal (45±1 kJ/kg,
consisting of 33% of energy from carbohydrate, 47% from
fat and 20% from protein).
Blood analysis Participants arrived at the hospital by car or
public transport and reported at the laboratory at 08:00 hours
following an overnight fast. After 20 min of supine rest, a
venous blood sample was collected. Thereafter, an OGTTwas
performed. Blood samples were immediately centrifuged at
1,000×g and 4°C for 5 min, after which plasma was frozen
in liquid nitrogen and stored at −80°C until analysis. Blood
samples were analysed for glucose (Beckman Synchron LX
20 Analyzer, Beckman Coulter, Fullerton, CA, USA), insulin
(Advia Centaur Immunoassay System, Bayer Diagnostics,
Tarrytown, NY, USA), HbA1c (Hi-Auto A1c Analyzer,
Menarini Diagnostics, Florence, Italy), total cholesterol,
HDL-cholesterol, LDL-cholesterol and total plasma triacyl-
glycerols (Beckman Synchron LX 20 Analyzer, Beckman
Coulter). Levels of NEFA were quantified by an enzymatic
method (Wako Chemicals, Neuss, Germany). The HOMA
index was calculated as an index of whole body insulin
sensitivity.
Whole body oxygen uptake and workload capacity Whole
body peak oxygen uptake V

O2peak
 
and maximal workload
capacity (Wmax) were assessed during an exhaustive
incremental exercise test on a cycle ergometer (Ergo
1500, Ergofit, Pirmasens, Germany) using a 3 min work
stage protocol. V

O2peak measurements were performed
continuously (CS 200, Schiller, Baar, Switzerland) to assess
V

O2peak. Cardiac function was monitored using a 12 lead
electrocardiogram with heart rate recorded continuously.
Muscle-tissue analysis In the morning, following an over-
night fast, a muscle biopsy was collected from the vastus
lateralis muscle [19, 20]. Muscle samples were dissected and
freed from any visible non-muscle material. Thereafter, the
muscle samples were rapidly frozen in liquid-nitrogen-
cooled isopentane.
Immunohistochemistry From the muscle samples, cryosec-
tions of 5 µm thickness were cut. Cryosections from samples
collected prior to the intervention period and after 2 and
6 months of intervention from each individual participant were
thaw mounted together on uncoated glass slides. After a 5 min
fixation step, the cryosections were incubated for 45 min with
antibodies against human laminin (polyclonal rabbit antibody,
Sigma Diagnostics, Steinheim, Germany), human slow myo-
sin heavy chain (A4.840) and human fast myosin heavy chain
(N2.261) in 0.05% Tween 20–PBS, enabling visualisation of
individual cell membranes and muscle fibre typing (type 1 and
2a), respectively. Incubation was followed by rinsing in PBS,
after which the appropriate conjugated antibodies, i.e. goat
anti-rabbit IgG (Alexa488) or goat anti-mouse IgM (Alexa350;
Molecular Probes, Leiden, the Netherlands) were applied for
30 min. After the final washes in PBS, the slides were mounted
with Mowiol.
All images were digitally captured using fluorescence
microscopy with a Nikon E800 fluorescence microscope
(Nikon Instruments Europe, Badhoevedorp, the Netherlands)
coupled to a Basler A113 C progressive scan colour charge
coupled device (CCD) camera with a Bayer colour filter. The
epifluorescence signal was recorded using a FITC excitation
filter (465–495 nm) for laminin, a Texas Red excitation filter
(540–580 nm) for slow myosin heavy chain and a DAPI UV
excitation filter (340–380 nm) for fast myosin heavy chain.
Image processing and quantitative analyses were performed
using the Lucia 4.81 software package (Nikon).
Oxidative enzyme activity assays Skeletal muscle citrate
synthase, cytochrome c oxidase, succinate dehydrogenase
and β-hydroxyacyl-CoA dehydrogenase activity were
assessed in 40 mg mixed muscle tissue. For the assessment
Last training 
bout or 8 days 
prior to start of 
intervention + 3 days + 8 days
Food intake 
standardisation
08.00 hours 
Fasting blood 
sample (t=0 min)
OGTT (t=15 min)
Exercise testing 
(t=140 min)
08.00 hours 
Fasting muscle 
biopsy (t=0 min)
DEXA scan (t=30 
min)
Food intake 
standardisation
+ 4 days + 7 days+ 1 day
Discontinuation of 
medication intake
Cessation of 
exercise 
training
Fig. 1 Study design. These
steps were performed for each
participant 1 week prior to the
intervention and at 2 and
6 months of exercise training.
On the experimental day, par-
ticipants reported to the labora-
tory at 08:00 hours following an
overnight fast. DEXA, dual-
energy X-ray absorptiometry
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of succinate dehydrogenase and cytochrome c oxidase, a
5% (wt/vol.) muscle homogenate was prepared in SET
buffer (based on sucrose (250 nmol/l), EDTA (2 mmol/l)
and TRIS (10 mmol/l), pH 7.4). The homogenate was
mixed with the KCl/glutathione/EDTA buffers (potassium
chloride [175 nmol/l], glutathione [10 mmol/l] and EDTA
[2 mmol/l], pH 7.4; 1:1 ratio) for the analysis of succinate
dehydrogenase activity. For cytochrome c oxidase activity,
140 μl phosphate buffer 50 mmol/l (pH 7.4), 10 μl muscle
homogenate (5%, wt/vol.) and 100 μl digitonin–BSA were
mixed. For the measurement of muscle citrate synthase
and β-hydroxyacyl-CoA dehydrogenase activity, a 2.5%
(wt/vol.) muscle homogenate was prepared in SET buffer.
Citrate synthase activity was measured by monitoring the
formation of CoA-DTNB (5,5′-dithio-bis[2-nitrobenzoic
acid]) during the citrate synthase reaction spectrophotomet-
rically at 412 nm. Cytochrome c oxidase activity was
assessed by monitoring the amount of reduced cytochrome
c during oxidation spectrophotometrically at 550 nm.
Succinate dehydrogenase activity was determined by
monitoring the reduction of Fe3+ in the K3[Fe(CN)6]
complex during the oxidation of succinate spectrophoto-
metrically at 420 nm. β-Hydroxyacyl-CoA dehydrogenase
activity was measured by monitoring the dehydrogenation
of NADH during the reduction of acetoacetyl-CoA spec-
trophotometrically at 340 nm.
Body composition Body mass was measured using a
calibrated analogue weight scale. Segmental and whole
body fat mass and fat-free mass were determined using
whole body dual X-ray absorptiometry (DEXA; Lunar
DPXL, WI, USA).
Exercise training intervention All participants performed
three individually supervised, continuous endurance-type
exercise sessions per week during a 6 month intervention
period within the rehabilitation centre of the hospital.
During each training session, walking, cycling and cross-
country ski-type exercise was performed. In the LI exercise
programme, each exercise session consisted of 55 min
exercise at a heart rate corresponding with exercise
performed at exactly 50% of baseline V

O2peak (heart rate
105±3 beats per min). In the HI exercise programme, each
exercise session consisted of 40 min exercise at a heart rate
corresponding with exercise performed at exactly 75% of
baseline V

O2peak (heart rate 118±3 beats per min). The
exercise training intensity was standardised by continuous
heart rate monitoring (Polar, Oy, Finland). Total energy
expenditure during the exercise training sessions was
matched between groups (1.30±0.05 MJ per session). As
the target heart rate was maintained throughout the exercise
training programme and maximal workload capacity in-
creased, energy expenditure during each exercise session
gradually increased in both groups (from 1.08±0.04 MJ per
session in week 1 to 1.34±0.05 MJ per session by week
24). After 2 months of exercise training, the relation
between heart rate and V

O2peak was re-assessed to recalcu-
late the target heart rate (at 50% or 75% V

O2peak). This
target was maintained for the remaining 4 month interven-
tion period.
During the 6 month exercise intervention programme,
daily habitual physical activity was assessed over a 14 day
period every 2 months using the International Physical
Activity Questionnaire. In addition, dietary intake was
recorded over the same 14 day period using a dietary
intake questionnaire.
Statistical analysis Data are expressed as means±SEM. Data
were analysed according to the intention-to-treat principle. To
minimise type I errors and loss of power, endpoint analyses
according to the ‘last observation carried forward’ principle
were performed for missing values at 6 months of follow-up.
To assess whether differences existed between the application
of the HI and LI training regimens, we used two-way ANOVA
with treatment (LI and HI) and time as the two factors. For
non-time-dependent variables, one-way ANOVAwas applied.
Relations of changes between variables were examined with
Pearson correlation coefficients. Statistical significance was
set at p<0.05. All calculations were performed using the
Statistical Package for the Social Sciences, version 13.0.
Results
Participants Participants (n=50, BMI 32±4 kg/m2, age
59±8 years) had been diagnosed with type 2 diabetes for
5±1 years and were using oral blood-glucose-lowering
medication (in the HI and LI groups, respectively: sulfamides,
24% and 40%; biguanides, 72% and 80%; alpha-glucosidase
inhibitors, 8% and 8%; thiazolidinediones, 8% and 8%; there
were no significant differences between the groups). Prior to
the intervention, participants engaged in 74±19 min/week
physical exercise (0.8±0.2 days/week for 36±9 min of
exercise/day). Thirty-four participants did not engage in any
physical activity and two engaged in high intensity exercises.
Participants were randomly assigned to either the LI or
HI training regimen. Participants’ characteristics are
reported in Table 1. All patients completed 2 months of
exercise training (and were re-evaluated), whereas 37
participants completed the entire 6 month programme.
Eight participants dropped out from the HI training regimen
and five from the LI training group before completing the
full 6 months of intervention. On average, 64±2 and 64±2
of the 72 exercise sessions were attended by the participants
who completed the exercise programme, resulting in an
overall compliance of 89±2% and 89±3% in the LI and HI
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training groups, respectively. The blood-glucose-lowering
medication dose had to be reduced in six participants (three
in the LI group and three in the HI group).
Food intake and physical activity Energy expenditure was
similar between groups and averaged 1.3±0.08 and 1.3±
0.07 MJ per session, or 85.4±5.0 and 82.4±4.5 MJ for the
entire LI and HI exercise training programme, respectively.
Prior to intervention, food intake averaged 12.7±1.4 MJ/day,
consisting of 41.2±1.5% energy from carbohydrate, 33.4±
1.5% from fat and 21.9±0.8% from protein. No differences
were observed between groups. Food intake, assessed on a
2 monthly basis, did not change significantly throughout the
intervention and averaged 10.9±1.8 MJ and 11.9±1.6 MJ
(2 months) and 10.2±1.6 MJ and 13.6±2.2 MJ (6 months)
per day in the LI and HI groups, respectively. In accordance,
the macronutrient composition of the diet did not change
over time and did not differ between groups (data not
shown).
Total sport and/or recreational physical activity, unrelat-
ed to the exercise performed within the intervention
programme, did not change throughout the intervention
programme (from 74±19 to 52±13 min exercise per week)
and did not differ between groups (from 58±20 and 9±
6 min to 18±10 and 6±6 min of moderate and vigorous
intensity exercise, respectively, in the HI group, and from
81±23 and 0±0 min to 67±15 and 13±6 min of moderate
and vigorous intensity exercise, respectively, in the LI
group). However, total sport and recreational physical
activity (including the exercise implemented in the inter-
vention programme) increased significantly throughout the
intervention (from 81±32 and 67±20 min to 244±21 and
144±11 min of exercise per week in the LI and HI groups,
respectively, p<0.05). The total time attributed to sport and
recreational physical activity was significantly greater in the
LI vs the HI exercise intervention group (p<0.05), as the
supervised exercise sessions were 15 min longer in the LI
than in the HI exercise training regimen.
Blood analyses Blood HbA1c content decreased from 7.2±
0.2% to 6.9±0.2% following exercise training (p<0.05;
Table 2). No interaction was observed between exercise
intensity and the decrease in blood HbA1c content. Basal
plasma glucose and insulin levels and indices of glucose
tolerance and/or whole body insulin sensitivity, all assessed
3 days after discontinuation of oral blood-glucose-lowering
medication, did not change following 2 and 6 months of
intervention. Furthermore, plasma LDL-cholesterol levels
decreased following exercise training (p<0.01), with no
differences between groups (p>0.05).
Maximal workload and whole body oxygen uptake capaci-
ty Maximal workload capacity and whole body peak
oxygen uptake increased significantly following exercise
training (p<0.001; Table 2), with no differences between
groups after 6 months of intervention. However, there was a
significant interaction effect (exercise training×intensity)
for the changes in VO2peak after 2 months of exercise
training. V

O2peak increased to a greater extent in the HI-
training group than in the group following the LI
programme (16±2% vs 9±2%, respectively; p<0.05). No
changes were observed in maximal heart rate. No correla-
tions were found between changes in V

O2peak and blood
HbA1c levels (p>0.05).
Table 1 Participant characteristics
Characteristic LI group HI group
n 25 25
Age (years) 58±1 59±2
Body weight (kg) 98.7±3.2 97.7±3.2
Body mass index (kg/m2) 32.7±0.8 32.1±0.9
Time since diagnosis (years) 4.0±0.8 5.1±0.8
Whole body insulin sensitivity and glycaemic control
Fasting glucose (mmol/l) a 9.8±0.6 9.7±0.4
Fasting insulin (pmol/l) a 147±24 128±10
HOMA indexa 8.5±1.3 7.7±0.8
HbA1c (%) 7.4±0.3 7.1±0.2
AUC OGTT (mol/l × min) a 1.76±0.08 1.83±0.08
Blood lipid profile
Triacylglycerols (mmol/l) 1.7±0.19 1.7±0.18
HDL-cholesterol (mmol/l) 1.1±0.04 1.1±0.05
LDL-cholesterol (mmol/l) 3.1±0.14 3.3±0.14
LDL/HDL ratio 2.9±0.16 3.2±0.16
Total cholesterol (mmol/l) 4.9±0.19 5.0±0.13
NEFA (mmol/l) 425±27 444±18
Body composition
Trunk fat mass (kg) 22.1±1.3 21.6±1.4
Legs fat mass (kg) 7.7±0.7 7.3±0.8
Trunk lean mass (kg) 31.3±0.7 31.4±0.6
Legs lean mass (kg) 18.8±0.5 18.9±0.4
Exercise performance
V

O2peak (l/min) 2.05±0.11 1.99±0.09
V

O2peak (ml kg
−1 min−1) 20.9±1.0 20.8±1.1
Maximal workload capacity (W) 161±7 169±6
Maximal workload capacity (W/kg) 1.7±0.1 1.8±0.1
Maximal heart rate (beats per min) 139±4 139±3
Data are means±SEM
Values for leg lean and fat mass are expressed as averages of
measurements of both legs
a Fasting glucose, insulin, HOMA index and AUC OGTT were
determined from an OGTT performed after 3 days of discontinuation
of habitual use of oral blood-glucose and lipid-lowering medication
No significant differences were observed between groups (p>0.05)
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Body composition Exercise training significantly reduced
body weight, body mass index and trunk fat mass (p<0.05;
Table 2). The change in trunk fat mass after 6 months of
intervention significantly differed between groups (p<0.05),
with decreases of 2.0±0.4 kg and 1.0±0.4 kg in the HI and
LI training groups, respectively. No interaction effect was
observed after 2 months of intervention (p>0.05). Trunk and
leg muscle mass increased significantly following the
exercise programme (p<0.05), with no differences between
groups (Table 2).
Muscle tissue analysis The oxidative enzyme activity of the
skeletal muscle and the skeletal muscle fibre type compo-
sition before and after 2 and 6 months of exercise training
are shown in Table 3. The distribution of skeletal muscle
fibre types and the activities of succinate dehydrogenase
and β-hydroxyacyl-CoA dehydrogenase did not change
after 2 or 6 months of intervention (p>0.05). In contrast,
cytochrome c oxidase and citrate synthase activity in-
creased by 56±16% and 46±22% following 6 months of
exercise training, respectively (p<0.05), with no differences
between groups. No significant correlations were observed
between changes in skeletal-muscle oxidative enzyme
activity and blood HbA1c levels (p>0.05).
Discussion
In this study, the clinical benefits of 6 months of continuous LI
vs HI endurance-type exercise training were assessed in obese
Table 2 The clinical benefits of exercise intervention
Variable Assessment Effect of
training
(p value)
Interaction
between
training and
intensity
(p value)
LI group HI group
Baseline 2 months 6 months Baseline 2 months 6 months
Whole body insulin sensitivity and glycaemic control
Fasting glucose (mmol/l)a 9.8±0.6 9.6±0.6 9.7±0.6 9.7±0.4 9.4±0.4 9.2±0.4
Fasting insulin (pmol/l)a 147±24 174±29 170±25 128±10 123±9 119±9
HOMA indexa 8.4±1.3 9.9±1.6 10.1±1.5 7.7±0.8 7.1±0.7 6.5±0.6
HbA1c (%) 7.4±0.3 7.3±0.3 7.2±0.3 7.1±0.2 6.9±0.2 6.6±0.18 <0.01
AUC OGTT (mol/min/l)a 1.76±0.08 1.68±0.08 1.75±0.08 1.83±0.08 1.78±0.07 1.71±0.08
Blood lipid profile
Triacylglycerols (mmol/l) 1.7±0.19 1.7±0.19 1.6±0.18 1.7±0.18 1.8±0.18 1.6±0.17
HDL-cholesterol (mmol/l) 1.1±0.04 1.0±0.03 1.0±0.04 1.1±0.05 1.1±0.04 1.1±0.05
LDL-cholesterol (mmol/l) 3.1±0.14 3.0±0.15 2.8±0.14 3.3±0.14 3.2±0.17 3.1±0.13 <0.01
LDL/HDL ratio 2.9±0.16 2.9±0.18 2.8±0.20 3.2±0.16 3.1±0.17 2.9±0.16
Total cholesterol (mmol/l) 4.9±0.19 4.8±0.28 4.7±0.26 5.0±0.13 4.9±0.17 4.7±0.15
NEFA (mmol/l) 425±27 427±26 428±31 444±18 491±33 461±33
Body composition
Body weight (kg) 98.7±3.2 98.0±3.3 97.6±3.4 97.7±3.2 96.7±3.1 95.9±3.2 <0.01
Body mass index (kg/m2) 32.7±0.8 32.4±0.9 32.3±0.9 32.1±0.9 31.7±0.9 31.4±0.9 <0.01
Trunk fat mass (kg) 22.1±1.3 21.3±1.3 21.1±1.4 21.6±1.4 20.4±1.2 19.6±1.2 <0.01 <0.05
Legs fat mass (kg) 7.7±0.7 7.7±0.7 7.5±0.8 7.3±0.8 7.1±0.7 6.9±0.7 <0.01
Trunk lean mass (kg) 31.3±0.7 31.9±0.7 32.2±0.7 31.4±0.6 32.1±0.8 32.5±0.8 <0.01
Legs lean mass (kg) 18.8±0.5 19.1±0.6 19.4±0.6 18.9±0.4 19.4±0.5 19.6±0.5 <0.01
Exercise performance
V

O2peak (l/min) 2.05±0.11 2.21±0.12 2.26±0.10 1.99±0.09 2.31±0.11 2.32±0.11 <0.001
V

O2peak (ml kg
−1 min−1) 20.9±1.0 22.7±1.1 23.5±1.1 20.8±1.1 24.3±1.2 24.7±1.2 <0.001
Maximal workload capacity (W) 161±7 173±8 184±8 169±6 180±7 185±7 <0.001
Maximal workload capacity (W/kg) 1.7±0.1 1.8±0.1 1.9±0.1 1.8±0.1 1.9±0.1 2.0±0.1 <0.001
Maximal heart rate (beats per min) 139±4 138±3 141±3 139±3 140±3 139±3
Data are means±SEM. Values for leg lean and fat mass are expressed as averages of measurements of both legs
a Fasting glucose, insulin, HOMA index and AUC OGTT were determined from an OGTT performed after 3 days of discontinuation of habitual
use of oral blood-glucose and lipid-lowering medication
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type 2 diabetes patients. After 6 months of intervention, blood
HbA1c content, body composition and whole body and
skeletal muscle oxidative capacity had improved significant-
ly, with no differences between the two groups.
It has been firmly established that regular exercise
effectively lowers blood HbA1c content in type 2 diabetes
patients [1–5]. In accordance, we observed a significant
reduction in blood HbA1c level following 2 and 6 months
of exercise intervention in the obese type 2 diabetes patients
(Table 2). It has been well established that the magnitude of
the reduction in HbA1c content following prolonged
exercise intervention strongly depends on pre-intervention
HbA1c levels [4]. In the present study, we observed a 0.3%
reduction in HbA1c level from the pre-intervention level of
7.2±0.2%. This represents a clinically relevant decline and
translates into a 6% reduction in the risk of premature death
and an 11% reduction in the risk of microvascular disease
[21]. Furthermore, none of the participants had to increase
oral blood-glucose-lowering medication within the 6 month
intervention period. In contrast, six participants had to
lower their medication dose. Though we confirm the
benefits of exercise intervention to lower blood HbA1c in
type 2 diabetes patients, it still remains to be established
which exercise training modalities should be applied to
maximise the clinical benefits of exercise intervention
[1, 5]. Some suggest that (relatively) high intensity exercise
activities are required to effectively improve glycaemic
control [8, 9]. However, others have failed to observe
differences in the acute effects of a low-to-moderate vs a
high intensity exercise bout on subsequent glycaemic
control in type 2 diabetes patients, when exercise bouts
were matched for total energy cost [12, 13].
Surprisingly, long-term intervention studies investigating
the impact of exercise intensity on the clinical benefits of
exercise training in type 2 diabetes patients are lacking.
Therefore, in the present study, we compared the impact of
continuous LI with HI endurance-type exercise training,
matched for total energy expenditure, in type 2 diabetes
patients. Even though 6 months of endurance-type exercise
training significantly lowered blood HbA1c, this reduction
did not differ between the groups undertaking the LI and HI
exercise regimens (Table 2). Furthermore, no changes were
observed in basal blood glucose and insulin concentrations
and/or in the glucose response in the oral glucose tolerance
tests. The present findings tend to be in line with previous
observations of the acute effects of a low vs a high intensity
exercise bout on glucose tolerance [12, 13], and indicate
that the implementation of continuous high intensity
endurance-type exercise is not required to lower blood
HbA1c during more prolonged exercise intervention in
obese type 2 diabetes patients. However, it should be noted
that there is recent evidence showing that more intense
interval-type exercise training is more effective than
continuous-type exercise training in various metabolically
and/or functionally compromised populations [22–24].
However, the clinical benefits and feasibility of high
intensity interval training remain to be established in type
2 diabetes patients.
The present findings suggest that prolonged continuous
low-to-moderate-intensity exercise training is equally ef-
fective when compared with more intense exercise training
as a means to lower blood HbA1c content, when exercise
bouts are being matched for total energy expenditure. This
is of important clinical relevance, as patients with long-
Table 3 Distribution of skeletal muscle fibre type and oxidative capacity
Variable Assessment Effect of training
LI group HI group
Baseline 2 months 6 months Baseline 2 months 6 months
Skeletal muscle fibre distribution (% CSA)
Type 1 muscle fibre 49.3±1.9 50.2±2.1 52.2±2.6 49.3±1.6 49.7±1.9 49.7±1.9
Type 2a muscle fibre 44.5±1.7 42.9±1.9 41.8±2.2 44.0±1.4 42.9±1.9 41.8±2.2
Type 2x muscle fibre 6.2±0.9 6.9±0.8 6.0±0.7 6.7±1.0 7.9±1.0 8.5±1.1
Oxidative enzyme activity (µmol [g wet weight]−1min−1)
Succinate dehydrogenase 13.3±0.4 12.7±0.3 12.8±0.3 13.7±0.4 12.9±0.4 14.3±0.5
Cytochrome c oxidase 5.2±0.6 6.0±0.7 7.4±0.9 4.5±0.4 5.8±0.6 6.5±0.7 <0.01
Citrate synthase 9.5±0.9 11.1±1.3 12.9±1.1 10.2±0.9 9.9±0.9 11.9±0.9 <0.01
β-Hydroxyacyl-CoA dehydrogenase 4.8±0.7 5.7±0.8 6.4±0.7 5.6±0.6 4.9±0.6 6.1±0.7
Data are means±SEM
CSA, fibre cross-sectional area
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standing type 2 diabetes generally suffer from muscle
weakness, cardiovascular co-morbidities and reduced exer-
cise tolerance. Consequently, it has proven difficult to engage
sedentary patients with type 2 diabetes in more intense exercise
intervention programmes [25]. As an inverse relationship
exists between exercise training intensity and patients’
adherence to an exercise intervention programme [18], it is
not surprising that the implementation of a relative high
intensity exercise regimen is generally associated with low
patient adherence and higher dropout rates [18]. In accor-
dance, we observed a greater dropout rate from the HI group
(n=8) than from the LI group (n=5), though this did not reach
statistical significance (p>0.05). From the present findings, we
conclude that the implementation of a continuous high
intensity exercise programme is not required to lower blood
HbA1c content in obese type 2 diabetes patients. Consequent-
ly, a less intense continuous endurance-type exercise regimen
can be equally effective when longer duration of exercise
compensates for the lower exercise intensity.
Endurance-type exercise is generally implemented as the
main type of exercise in diabetes intervention programmes
to effectively reduce whole body fat mass. Historically,
low-to-moderate intensity endurance-type exercise has been
prescribed to maximise oxidation of skeletal muscle fat [26]
and thus maximise loss of fat mass. In the present study, we
observed improvements in body composition, including an
increase in skeletal muscle mass and a decline in body fat
mass following 2 and 6 months of exercise intervention
(Table 2). We observed a significantly greater reduction in
trunk fat mass in the group undergoing HI exercise than in
those undergoing LI training (Table 2). Although this may
reflect a greater lipolytic response in adipose tissue during
post-exercise recovery from more intense exercise [27], the
greater loss of trunk fat mass in the HI group was not
accompanied by a measurable increase in oral glucose
tolerance and/or whole body insulin sensitivity.
A low oxidative capacity of skeletal muscle has been
associated with reduced fat oxidative capacity and greater
risk of developing obesity, insulin resistance and/or type 2
diabetes. This has raised the question as to whether
impaired mitochondrial function might represent an impor-
tant factor in the aetiology of insulin resistance [28]. In line
with observations of differences in the morphological
structure of skeletal muscle mitochondria in patients with
type 2 diabetes [28], reduced rates of expression of multiple
nuclear respiratory factor-1-dependent genes have been
reported in muscle tissue obtained from type 2 diabetes
patients [29]. Furthermore, studies applying 31P-magnetic
resonance spectroscopy (MRS) with the intention to assess
in vivo muscle mitochondrial function suggest the presence
of impairments in mitochondrial function in insulin-
resistant elderly men and the insulin-resistant offspring of
people with type 2 diabetes [30]. However, a significant
limitation of these studies is that during the 31P-MRS
measurements, O2 flux was not normalised for mitochondrial
content. When normalised, both oxidative phosphorylation
and electron-transport capacity do not seem to be impaired in
type 2 diabetes patients [31]. Therefore, mitochondrial
dysfunction does not represent a cause but rather a
consequence of the obese insulin-resistant and/or type 2
diabetic state [31, 32]. Prospective long-term training studies
aiming to prevent or treat insulin resistance and type 2
diabetes are warranted to determine to what extent the
proposed impairments in mitochondrial function can be
remedied. In the present study, we observed increases in
whole body oxygen uptake capacity (V

O2peak: +16±4%) and
skeletal muscle oxidative enzyme activity (cytochrome c
oxidase: +56±16% and citrate synthase: +46±22%; Table 3)
following 6 months of exercise training. As no interactions
were observed within this timeframe, we conclude that
continuous moderate-to-high intensity exercise training does
not further augment V

O2peak or skeletal muscle oxidative
capacity when compared with a less intense exercise
regimen. Moreover, changes in V

O2peak and skeletal muscle
oxidative enzyme activity did not correlate with the decline
in blood HbA1c levels. Interestingly, the continuous HI
exercise regimen tended to result in a faster increase in
V

O2peak during the first 2 months of the intervention
programme. However, this was no longer apparent after
6 months of exercise training (Table 2).
In conclusion, despite a smaller decline in trunk fat mass,
prolonged continuous moderate-to-high intensity endurance
type exercise is equally as effective as low-to-moderate
intensity exercise training at lowering blood HbA1c, elevat-
ing muscle mass and increasing whole body and skeletal
muscle oxidative capacity in obese type 2 diabetes patients.
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